The world has come a long way in preventing and treating HIV, but tens of thousands of Canadians still live with it, and it continues to spread. Dr. Darrell Tan, Canada Research Chair in HIV Prevention and STI Research, aims to reduce the number of people affected by the disease. Tan is trying to figure out how new HIV prevention technologies—such as pre- and post-exposure prophylaxis (PrEP/PEP)—can best be used to end new HIV infections in Canada.
He and his research team are drawing on clinical training in infectious diseases, research training in clinical epidemiology, theoretical frameworks from implementation science, and community-based research principles. Their main objectives are to test strategies for targeting PrEP delivery to those at greatest risk, study new ways to build clinical capacity to deliver PrEP/PEP, and evaluate outcomes among patients using these promising new tools.